Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EXO Biologics logo — Discovering the power of exosomes as future nanomedicines

EXO Biologics

Discovering the power of exosomes as future nanomedicines

Founded 2019 Belgium Belgium 23 employees Biopharma, Biotechnology +1

General Information

Company Name EXO Biologics
Founded Year 2019
Location Belgium Belgium +2
Employees 23
Industries Biopharma, Biotechnology, Life Sciences
Social

Get notified when EXO Biologics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EXO Biologics

EXO Biologics is a Belgian clinical-stage biotechnology company that is dedicated to researching and developing novel sub-cellular therapeutic candidates based on exosomes. The company's slogan "Discovering the power of exosomes as future nanomedicines" reflects its commitment to harnessing the potential of exosomes in the field of nanomedicine. Founded in 2019, EXO Biologics has a mission to provide affordable and accessible exosome therapies to patients with unmet medical needs. One of the key strengths of EXO Biologics lies in its strong partnerships and influential networks, which involve collaborations with research centers, public universities, and private partners. These collaborations are instrumental in enabling the company to conduct cutting-edge research and develop innovative medical treatments in the Biopharma and Biotechnology sectors. As of now, specific details about the last investment round and the participating investors are not available. Nonetheless, given its focus on pioneering research and its commitment to addressing unmet medical needs, EXO Biologics presents an intriguing opportunity for potential venture capital investment. The company's emphasis on leveraging exosomes for therapeutic purposes, combined with its strategic location in Belgium, contributes to its potential for long-term growth and impact in the biotechnology industry.

Taxonomy: Clinical-stage, Research and Development, Exosomes, Nanomedicines, Therapeutic Candidates, Medical Treatments, Partnerships, Clinical Research, University Partnerships

No funding data available for EXO Biologics yet.

Get notified when EXO Biologics raises funding

Latest News

View All
April’s early-stage funding wrapup: Big month for healthtech and UK maintains its crown — Sifted
April’s early-stage funding wrapup: Big month for healthtech and UK maintains its crown
Sifted May 10, 2024

EXO Biologics Alternatives & Competitors

EXO Biologics vs
ILIAS Biologics Inc.
ILIAS Biologics Inc. Korea South

The Global Leader in Exosome-based Therapeutics

Series B
18 employees
Biopharma, Biotechnology
EXO Biologics vs
WuXi Clinical
WuXi Clinical United States

We are a global clinical research organization (CRO)

88 employees
Health Care
EXO Biologics vs
Precise Research Centers
Precise Research Centers United States

Premier clinical research site in Mississippi founded in 2004 by Dr. Joseph Kwentus.

7 employees
Health Care, Health and Wellness

FAQ About EXO Biologics

Discovering the power of exosomes as future nanomedicines
EXO Biologics was founded in 2019.
EXO Biologics is headquartered in Belgium.
EXO Biologics operates in the following industries: Biopharma, Biotechnology, Life Sciences.
EXO Biologics has approximately 23 employees.
Top alternatives and competitors to EXO Biologics include ILIAS Biologics Inc., WuXi Clinical, Precise Research Centers, Western States Clinical Research, Inc., Biologics Consulting. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EXO Biologics and ILIAS Biologics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EXO Biologics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy